Literature DB >> 10462689

Comparative study of the distribution of calmodulin kinase II and calcineurin in the mouse brain.

C Solà1, J M Tusell, J Serratosa.   

Abstract

The Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and the phosphatase calcineurin (CaN) are Ca(2+)/calmodulin-binding proteins that are very abundant in the central nervous system. In the mammalian brain, CaMKII is composed by the association of several similar subunits at different ratios produced by four different genes. CaN is composed of two different subunits produced by two genes. We selected the most abundant subunits of each enzyme in the rodent brain, CaMKII alpha and CaN A, and compared their pattern of expression in the mouse brain by using in situ hybridization histochemistry and immunohistochemistry. We found that CaMKII and CaN were mainly expressed in cerebral cortex, hippocampus, and striatum and that low levels of expression were observed in midbrain and brainstem. CaN was also expressed in cerebellum. In the cell, the kinase and the phosphatase were detected in the perikarya, the neuronal processes, and the nucleus. The present study shows that all the regions of the mouse brain in which CaMKII is expressed also show CaN expression. This fact is consistent with the presence of common substrates for both enzymes or with a regulatory action of one versus the other. The lack of correspondence in the cerebellum could be explained by the fact that the major subunit of the kinase in this brain region is CaMKII beta. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462689

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  21 in total

1.  Inhibition of the NFAT pathway alleviates amyloid β neurotoxicity in a mouse model of Alzheimer's disease.

Authors:  Eloise Hudry; Hai-Yan Wu; Michal Arbel-Ornath; Tadafumi Hashimoto; Roland Matsouaka; Zhanyun Fan; Tara L Spires-Jones; Rebecca A Betensky; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

2.  Role of CA2+/calmodulin on ethanol neurobehavioral effects.

Authors:  Pablo Baliño; Juan Carlos Ledesma; Carlos M G Aragon
Journal:  Psychopharmacology (Berl)       Date:  2014-05-23       Impact factor: 4.530

Review 3.  Calcineurin signaling as a target for the treatment of alcohol abuse and neuroinflammatory disorders.

Authors:  Patrick J Ronan; Sarah A Flynn; Thomas P Beresford
Journal:  Prog Mol Biol Transl Sci       Date:  2019-08-12       Impact factor: 3.622

4.  Camk2a-Cre-mediated conditional deletion of chromatin remodeler Brg1 causes perinatal hydrocephalus.

Authors:  Mou Cao; Jiang I Wu
Journal:  Neurosci Lett       Date:  2015-04-27       Impact factor: 3.046

5.  NR2B-deficient mice are more sensitive to the locomotor stimulant and depressant effects of ethanol.

Authors:  Kimberly A Badanich; Tamara L Doremus-Fitzwater; Patrick J Mulholland; Patrick K Randall; Eric Delpire; Howard C Becker
Journal:  Genes Brain Behav       Date:  2011-08-15       Impact factor: 3.449

6.  H3.3 Barcoding of Nucleus Accumbens Transcriptional Activity Identifies Novel Molecular Cascades Associated with Cocaine Self-administration in Mice.

Authors:  Mathieu E Wimmer; Bruno Fant; Sarah E Swinford-Jackson; Alexander Testino; Duncan Van Nest; Ted Abel; R Christopher Pierce
Journal:  J Neurosci       Date:  2019-05-01       Impact factor: 6.167

7.  Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine.

Authors:  Jessica A Loweth; Bryan F Singer; Lorinda K Baker; Georgia Wilke; Hidetoshi Inamine; Nancy Bubula; John K Alexander; William A Carlezon; Rachael L Neve; Paul Vezina
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

8.  Targeted deletion of the gene encoding the La autoantigen (Sjögren's syndrome antigen B) in B cells or the frontal brain causes extensive tissue loss.

Authors:  Sergei Gaidamakov; Olga A Maximova; Hyongi Chon; Nathan H Blewett; Hongsheng Wang; Amanda K Crawford; Amanda Day; Natalie Tulchin; Robert J Crouch; Herbert C Morse; Robert D Blitzer; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

9.  Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.

Authors:  William J Meilandt; Moustapha Cisse; Kaitlyn Ho; Tiffany Wu; Luke A Esposito; Kimberly Scearce-Levie; Irene H Cheng; Gui-Qiu Yu; Lennart Mucke
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

10.  Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease.

Authors:  Jose R Pineda; Raúl Pardo; Diana Zala; Hua Yu; Sandrine Humbert; Frédéric Saudou
Journal:  Mol Brain       Date:  2009-10-27       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.